Dr Ellis's article (October 1999 JRSM, pp. 538±539) made me thankful that someone`out there' appreciated the true position about NICE. For months and months I and many others have tried to bring the plight of multiple sclerosis (MS) sufferers to the attention of the Government, health authorities and the media, but alas the media in particular seem to have an embargo on the subject. I approached the Prime Minister on Question Time only to be told that he was not quali®ed to answer my question but I could write to him. Months later I got a reply which virtually said NICE were to issue guidelines. My question to the Prime Minister was (and this was in writing)`Having regard to his manifesto could he say that NICE and other bodies will not be used to justify a refusal to fund treatment that a specialist has judged would be of bene®t to a patient or to delay treatment that a specialist is satis®ed is appropriate for his or her patient'? This has not been addressed. I have now learned that the decision on beta-interferon is likely to be delayed another eight or nine months.
We need someone like Dr Ellis behind usÐMS sufferers and their carers are just getting nowhere.
